Alexander R Anderson

56PUBLICATIONS

147CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Statistical mechanics, physical combinatorics and mathematical aspects of condensed matterCancer cell biology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (56)

Sort by Publication Date:

|May 29, 2026

Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies.

|May 22, 2026

Evolutionary antifragile therapy is a treatment strategy to suppress drug resistance by exploiting dose response convexity.

|Mar 27, 2026

A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind.

Rena Emond, Jeffrey West, Vince K Grolmusz

|Feb 06, 2026

75 Years of Mathematical Oncology.

Franco Pradelli, Maximilian Strobl, Sadegh Marzban

|Dec 19, 2025

Distinct Tumor-Immune Ecologies in Patients with Lung Cancer Predict Progression and Define a Clinical Biomarker of Therapy Response.

Sandhya Prabhakaran, Chandler D Gatenbee, Mark Robertson-Tessi

|Oct 17, 2025

Mathematical Oncology: How Modeling Is Transforming Clinical Decision-Making.

Kevin R Scibilia, Kit Gallagher, M A Masud

Pageof 10

Frequent Collaborators

17 joint publications

Jeffrey West

15 joint publications

Mark Robertson-Tessi

11 joint publications

Chandler Gatenbee

10 joint publications

Maximilian Strobl

10 joint publications

Robert Gatenby

10 joint publications

Jill Gallaher

Ryan O Schenck

Philip K Maini

Trevor Graham

Sandhya Prabhakaran

Frequent Collaborators

17 joint publications

Jeffrey West

15 joint publications

Mark Robertson-Tessi

11 joint publications

Chandler Gatenbee

10 joint publications

Maximilian Strobl